Use of Health Care Databases to Support Supplemental Indications of Approved Medications.

Volume: 178, Issue: 1, Pages: 55 - 63
Published: Jan 1, 2018
Abstract
Importance null Manufacturers of US Food and Drug Administration–approved prescription drugs often apply for additional indications based on randomized clinical trials. Real-world database analyses on a medication’s use and outcomes in routine settings of care might help to inform decision making regarding such supplemental indications. null Objective null To examine whether longitudinal data from a health care database can support the results...
Paper Details
Title
Use of Health Care Databases to Support Supplemental Indications of Approved Medications.
Published Date
Jan 1, 2018
Volume
178
Issue
1
Pages
55 - 63
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.